These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 17920899)

  • 1. Cowden syndrome.
    Gustafson S; Zbuk KM; Scacheri C; Eng C
    Semin Oncol; 2007 Oct; 34(5):428-34. PubMed ID: 17920899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN: one gene, many syndromes.
    Eng C
    Hum Mutat; 2003 Sep; 22(3):183-98. PubMed ID: 12938083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
    Ngeow J; Sesock K; Eng C
    Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes.
    Zhou X; Hampel H; Thiele H; Gorlin RJ; Hennekam RC; Parisi M; Winter RM; Eng C
    Lancet; 2001 Jul; 358(9277):210-1. PubMed ID: 11476841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
    Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
    Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
    Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
    PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN hamartoma tumor syndrome.
    Mester J; Charis E
    Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
    Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
    Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
    Zori RT; Marsh DJ; Graham GE; Marliss EB; Eng C
    Am J Med Genet; 1998 Dec; 80(4):399-402. PubMed ID: 9856571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway.
    Zhou XP; Waite KA; Pilarski R; Hampel H; Fernandez MJ; Bos C; Dasouki M; Feldman GL; Greenberg LA; Ivanovich J; Matloff E; Patterson A; Pierpont ME; Russo D; Nassif NT; Eng C
    Am J Hum Genet; 2003 Aug; 73(2):404-11. PubMed ID: 12844284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel dermatological and skeletal features associated with PTEN variant in PTEN hamartoma tumor syndrome.
    Comeau D; Allain V; Maillet-Lebel N; Ben Amor M
    Eur J Med Genet; 2023 Aug; 66(8):104798. PubMed ID: 37307869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.
    Hendriks YM; Verhallen JT; van der Smagt JJ; Kant SG; Hilhorst Y; Hoefsloot L; Hansson KB; van der Straaten PJ; Boutkan H; Breuning MH; Vasen HF; Bröcker-Vriends AH
    Fam Cancer; 2003; 2(2):79-85. PubMed ID: 14574156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
    Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
    Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
    Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
    Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into Clinical Disorders in Cowden Syndrome: A Comprehensive Review.
    Pîrlog LM; Pătrășcanu AA; Militaru MS; Cătană A
    Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
    Orloff MS; Eng C
    Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
    Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N
    Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN hamartoma tumor syndrome: an overview.
    Hobert JA; Eng C
    Genet Med; 2009 Oct; 11(10):687-94. PubMed ID: 19668082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
    Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
    Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.